QA: Sibannac Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001313938_2015_Sibannac_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001313938, Sibannac Inc

  xvar xval
0 AssetsCurrent 63,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 137,824
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 69,837
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -210,948
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 63,000
1 Liabilities 137,824
2 Expenses 69,837
3 Revenues 0
4 StockholdersEquity -74,824
5 NetIncome -280,785
6 ComprehensiveNetIncome -280,785
7 BaseVar 240,804
8 EconomicCapitalRatiobeforeLimitedLiability -4.42
9 EconomicCapitalRatio 0.295

Edgar->Model Mapping

Feature Distribution

Change over Time